-+ 0.00%
-+ 0.00%
-+ 0.00%

ENGENE HOLDINGS - SECURES UP TO $100 MLN FOR DETALIMOGENE DEVELOPMENT & COMMERCIALIZATION FOR BLADDER CANCER

Reuters·01/20/2026 22:37:29

Please log in to view news